XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Nature of the Business - Additional Information (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended
Dec. 16, 2022
shares
Dec. 14, 2022
USD ($)
Nov. 17, 2022
USD ($)
$ / shares
shares
Dec. 16, 2022
USD ($)
Jun. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
Jun. 30, 2022
USD ($)
shares
Mar. 31, 2022
USD ($)
shares
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
shares
Dec. 31, 2022
USD ($)
Nov. 18, 2022
shares
Dec. 31, 2021
shares
Organization Consolidation Presentation Of Financial Statements [Line Items]                          
Reverse stock split conversion ratio     0.406                    
Aggregate net proceeds from concurrent private placement     $ 4,700                    
Net loss         $ 13,914 $ 12,756 $ 5,820 $ 7,220 $ 26,670 $ 13,040      
Accumulated deficit         82,702       82,702   $ 56,032    
Cash, cash equivalents and investments         $ 151,000       $ 151,000        
Convertible Preferred Stock                          
Organization Consolidation Presentation Of Financial Statements [Line Items]                          
Convertible preferred stock outstanding | shares             27,471,911 27,471,911   27,471,911   0 27,471,911
Initial Public Offering                          
Organization Consolidation Presentation Of Financial Statements [Line Items]                          
Initial public offering price per share | $ / shares     $ 12.5                    
Description of reverse stock spilt                 In connection with the IPO, the Company effected a 1-for-2.466 reverse stock split of the Company’s common stock and adjusted the ratio at which the Company’s preferred stock is convertible into common stock, the number of shares available for issuance under the 2019 Stock Incentive Plan (“2019 Plan”) and the number of options and exercise prices of options granted under the 2019 Plan as a result of the 1-for-2.466 reverse stock split.        
Initial Public Offering | Common Stock                          
Organization Consolidation Presentation Of Financial Statements [Line Items]                          
Issuance of common stock | shares     7,550,000                    
Proceeds from Issuance Initial Public Offering     $ 94,400                    
Initial Public Offering | Common Stock | Convertible Preferred Stock                          
Organization Consolidation Presentation Of Financial Statements [Line Items]                          
Convertible preferred stock converted into common stock shares | shares     11,140,262                    
Concurrent Private Placement                          
Organization Consolidation Presentation Of Financial Statements [Line Items]                          
Initial public offering price per share | $ / shares     $ 12.5                    
Concurrent Private Placement | Common Stock                          
Organization Consolidation Presentation Of Financial Statements [Line Items]                          
Issuance of common stock | shares     400,000                    
Underwriters                          
Organization Consolidation Presentation Of Financial Statements [Line Items]                          
Issuance of common stock | shares 1,035,540                        
Gross proceeds from exercise of option   $ 12,900                      
Underwriters | Common Stock                          
Organization Consolidation Presentation Of Financial Statements [Line Items]                          
Underwriters option to purchase common stock | shares     1,132,500                    
IPO and Option Exercise                          
Organization Consolidation Presentation Of Financial Statements [Line Items]                          
Aggregate net proceeds received from IPO and option exercise   99,800                      
Payment of underwriting discounts and commissions       $ 7,500                  
Offering expenses payable   $ 3,600